Brown, Gordon T.Cash, BeatrizAlnabulsi, AyhamSamuel, Leslie M.Murray, Graeme I.2017-03-022017-03-022016-03Brown, G T, Cash, B, Alnabulsi, A, Samuel, L M & Murray, G I 2016, 'The expression and prognostic significance of bcl-2-associated transcription factor 1 in rectal cancer following neoadjuvant therapy', Histopathology, vol. 68, no. 4, pp. 556-566. https://doi.org/10.1111/his.127800309-0167ORCID: /0000-0002-8402-8670/work/50559791ORCID: /0000-0003-3981-2420/work/76973596http://hdl.handle.net/2164/8258Acknowledgements This study was supported by funding from the Encompass kick start and SMART:Scotland award schemes of Scottish Enterprise and Friends of Anchor. The Grampian Biorepository assisted with the immunohistochemical investigations.111396983engSDG 3 - Good Health and Well-beingbcl-2-associated transcription factor 1biomarkerimmunohistochemistrymonoclonal antibodyneoadjuvant therapyprognosisrectal cancerQH301 BiologyQH301Journal article10.1111/his.12780684